ANAPTYSBIO INC. - COMMON STOCK
19.65
08-May-25 11:17:05
15 minutes delayed
Stocks
-0.04
-0.18%
Today's range
18.51 - 19.65
ISIN
N/A
Source
NASDAQ
-
AnaptysBio Announces Third Quarter 2021 Financial Results and Provides Pipeline Updates
04 Nov 2021 16:05:03 By Nasdaq GlobeNewswire
-
25 Oct 2021 16:37:00 By Nasdaq GlobeNewswire
-
02 Oct 2021 12:00:00 By Nasdaq GlobeNewswire
-
AnaptysBio to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
09 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
-
17 Aug 2021 16:32:07 By Nasdaq GlobeNewswire
-
AnaptysBio to Present at the 2021 Jefferies Virtual Healthcare Conference
27 May 2021 16:15:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline Updates
04 May 2021 16:05:01 By Nasdaq GlobeNewswire
-
23 Apr 2021 10:31:07 By Nasdaq GlobeNewswire
-
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
22 Apr 2021 16:12:22 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of Oleg Nodelman to Board of Directors
12 Apr 2021 16:00:00 By Nasdaq GlobeNewswire
-
25 Feb 2021 16:05:01 By Nasdaq GlobeNewswire
-
AnaptysBio to Present at the 39th Annual J.P. Morgan Healthcare Conference
07 Jan 2021 16:15:00 By Nasdaq GlobeNewswire